Interleukin-13 receptor alpha 2 cooperates with EGFRvIII signaling to promote glioblastoma multiforme-Reference-Cited by-同舟云学术

Interleukin-13 receptor alpha 2 cooperates with EGFRvIII signaling to promote glioblastoma multiforme

Published:2017-12 Issue:1 Volume:8 Page:
ISSN:2041-1723
Container-title:Nature Communications
language:en
Short-container-title:Nat Commun

Author:

Newman Jennifer P.,Wang Grace Y.,Arima Kazuhiko,Guan Shou P.,Waters Michael R.,Cavenee Webster K.,Pan Edward,Aliwarga Edita,Chong Siao T.,Kok Catherine Y. L.,Endaya Berwini B.,Habib Amyn A.^ORCID,Horibe Tomohisa,Ng Wai H.,Ho Ivy A. W.,Hui Kam M.,Kordula Tomasz,Lam Paula Y. P.

Publisher

Springer Science and Business Media LLC

Subject

General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry

Link

http://www.nature.com/articles/s41467-017-01392-9.pdf

Reference58 articles.

1. Stupp, R. et al. Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide. J. Clin. Oncol. 20, 1375–1382 (2002).

2. Saikali, S. et al. Expression of nine tumour antigens in a series of human glioblastoma multiforme: interest of EGFRvIII, IL-13Ralpha2, gp100 and TRP-2 for immunotherapy. J. Neurooncol. 81, 139–148 (2007).

3. Wykosky, J., Gibo, D. M., Stanton, C. & Debinski, W. Interleukin-13 receptor alpha 2, EphA2, and Fos-related antigen 1 as molecular denominators of high-grade astrocytomas and specific targets for combinatorial therapy. Clin. Cancer Res. 14, 199–208 (2008).

4. Gan, H. K., Cvrljevic, A. N. & Johns, T. G. The epidermal growth factor receptor variant III (EGFRvIII): where wild things are altered. FEBS J. 280, 5350–5370 (2013).

5. Parsons, D. W. et al. An integrated genomic analysis of human glioblastoma multiforme. Science 321, 1807–1812 (2008).

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A call for clinical trials in glioblastoma multiforme for interleukin 4, interleukin 6, interleukin 13 and CD40;Neurosurgical Review;2024-09-07

2. Interleukin 4 and cancer resistance in glioblastoma multiforme;Neurosurgical Review;2024-08-21

3. Armored bicistronic CAR T cells with dominant-negative TGF-β receptor II to overcome resistance in glioblastoma;Molecular Therapy;2024-07

4. Understanding the immunosuppressive microenvironment of glioma: mechanistic insights and clinical perspectives;Journal of Hematology & Oncology;2024-05-08

5. Pooled screening for CAR function identifies novel IL13Rα2-targeted CARs for treatment of glioblastoma;2024-04-09